Large-scale peptide manufacturing at CordenPharma in Colorado (courtesy CordenPharma)
July 16, 2024 01:00 AM EDTUpdated 05:04 AM
Manufacturing

Cor­den­Phar­ma in­jects €900M to boost GLP-1 man­u­fac­tur­ing in US and Eu­rope

Anna Brown

News Reporter

In its biggest in­vest­ment so far, Cor­den­Phar­ma is ear­mark­ing €900 mil­lion ($982 mil­lion) over the next three years to ex­pand its pep­tide plat­form ca­pac­i­ty in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bio­phar­ma be­gins to con­tem­plate an RFK Jr.-in­flu­enced FDA if Trump wins

Pfiz­er shares new de­tails on obe­si­ty pipeline, hints at ‘oth­er op­por­tu­ni­ties’

GSK buys au­toim­mune T cell en­gager for $300M up­front from Chim­a­gen

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

No­var­tis high­lights over­all M&A track record fol­low­ing Mor­phoSys im­pair­ment

Fol­low­ing March in­spec­tion, No­vo Nordisk's semaglu­tide man­u­fac­tur­ing fa­cil­i­ty cit­ed by FDA

A service from the Financial Times